Molecular Templates Inc (MTEM)
1.67
-0.06
(-3.19%)
USD |
NASDAQ |
May 03, 16:00
1.70
+0.03
(+1.80%)
After-Hours: 20:00
Molecular Templates 1 Year Total Returns (Daily): -71.14% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -71.14% |
May 02, 2024 | -70.88% |
May 01, 2024 | -72.08% |
April 30, 2024 | -71.83% |
April 29, 2024 | -70.65% |
April 26, 2024 | -71.27% |
April 25, 2024 | -74.48% |
April 24, 2024 | -74.31% |
April 23, 2024 | -75.97% |
April 22, 2024 | -76.74% |
April 19, 2024 | -78.70% |
April 18, 2024 | -78.04% |
April 17, 2024 | -78.46% |
April 16, 2024 | -76.45% |
April 15, 2024 | -74.75% |
April 12, 2024 | -72.61% |
April 11, 2024 | -70.08% |
April 10, 2024 | -70.30% |
April 09, 2024 | -71.32% |
April 08, 2024 | -69.30% |
April 05, 2024 | -71.31% |
April 04, 2024 | -70.78% |
April 03, 2024 | -72.09% |
April 02, 2024 | -66.66% |
April 01, 2024 | -63.67% |
Date | Value |
---|---|
March 28, 2024 | -54.95% |
March 27, 2024 | -53.47% |
March 26, 2024 | -54.70% |
March 25, 2024 | -52.72% |
March 22, 2024 | -64.46% |
March 21, 2024 | -65.71% |
March 20, 2024 | -65.15% |
March 19, 2024 | -63.51% |
March 18, 2024 | -57.56% |
March 15, 2024 | -44.46% |
March 14, 2024 | -48.18% |
March 13, 2024 | -48.40% |
March 12, 2024 | -62.19% |
March 11, 2024 | -57.90% |
March 08, 2024 | -47.69% |
March 07, 2024 | -51.25% |
March 06, 2024 | -48.84% |
March 05, 2024 | -45.85% |
March 04, 2024 | -43.96% |
March 01, 2024 | -48.23% |
February 29, 2024 | -45.39% |
February 28, 2024 | -45.53% |
February 27, 2024 | -43.44% |
February 26, 2024 | -44.07% |
February 23, 2024 | -44.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.10%
Minimum
Dec 30 2022
309.3%
Maximum
Dec 23 2019
-10.71%
Average
-41.74%
Median
Jun 24 2021
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -15.65% |
Perspective Therapeutics Inc | 196.0% |
Protalix BioTherapeutics Inc | -63.81% |
Electromed Inc | 78.40% |
Armata Pharmaceuticals Inc | 61.69% |